SoylentNews

Freeman [soylentnews.org] writes:

https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ [arstechnica.com]

Infamous ex-pharmaceutical executive Martin Shkreli is yet again in trouble with the Federal Trade Commission, which announced today [ftc.gov] that the convicted fraudster has failed to cooperate with the commission's investigation into whether he violated his lifetime ban from the pharmaceutical industry by starting a company last year called "Druglike, Inc."
[...]
At the center of the dispute is whether Shkreli's co-founding of Druglike runs afoul of his lifetime ban from the pharmaceutical industry [arstechnica.com], which was in response to Shkreli's infamous move to raise the price of the cheap, life-saving anti-parasitic drug, Daraprim, from $17.50 a pill to $750 a pill in 2015.
[...]
The FTC also noted in its court filing that Shkreli has so far failed to pay any of the $64.6 million in disgorgement he was ordered to pay alongside his lifetime ban.

Previously:
Martin Shkreli Launches Blockchain-Based Drug Discovery Platform [soylentnews.org]
Martin Shkreli Accused of Running Business From Prison With a Smuggled Smartphone [soylentnews.org]
Sobbing Martin Shkreli Sentenced to 7 Years in Prison for Defrauding Investors [soylentnews.org]
Martin Shkreli's $5 Million Bail Revoked for Facebook Post Seeking Hillary Clinton's Hair [soylentnews.org]
Martin Shkreli Lists Unreleased Wu-Tang Clan Album on eBay [soylentnews.org]
Martin Shkreli Convicted of Securities Fraud Charges, Optimistic About Sentencing [soylentnews.org]
Martin Shkreli Points Fingers at Other Pharmaceutical Companies [soylentnews.org]

Related:
U.S. Hospitals Band Together to Form Civica Rx, a Non-Profit Pharmaceutical Company [soylentnews.org]
FDA Has Named Names of Pharma Companies Blocking Cheaper Generics [Updated] [soylentnews.org]
EpiPen Maker is Facing Shareholder Backlash [soylentnews.org]
Mylan Overcharged U.S. Government on EpiPens [soylentnews.org]
Drug Firm Offers $1 Version of $750 Turing Pharmaceuticals Pill [soylentnews.org]

Original Submission